Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy

Overview of attention for article published in Chinese Medicine, May 2022

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 1,373 followers.

New article: Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy https://t.co/ppUNU4S0w8 #breastcancer #oncology https://t.co/ITBQXjtfN7

Reply Repost Favourite

New article: Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy https://t.co/unpUpTlRmc #parkinsons #neurology https://t.co/cB7CAVfs1J

Reply Repost Favourite

New article: Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy https://t.co/m4AxPgnNJC #livercancer #oncology https://t.co/gjXNilgx1U

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.